Xiao Bo Lu
Director/Board Member at Qingdao Raisecare Biotechnology Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen John Kiel | M | 71 |
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Jun Cai Bai | M | 61 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Mi Sun | M | - |
Qingdao Raisecare Biotechnology Co., Ltd.
 Qingdao Raisecare Biotechnology Co., Ltd. Medical SpecialtiesHealth Technology Qingdao Raisecare Biotechnology Co., Ltd. is a pharmaceutical company founded in 2016. The private company is based in Qingdao, China and develops and promotes pharmaceutical chemicals and products. | 7 years |
| Liang Jin | M | 42 | 6 years | |
| Yue Ji | M | 51 |
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 19 years |
| Jian Sun | M | 42 | 4 years | |
| Guan Mu Dong | M | 72 | 4 years | |
| Eva Ip | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Craig Marshall Lea | M | 71 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 years |
| Ling Yun Chen | M | 45 | 2 years | |
| Fang Fang | F | 45 | 11 years | |
| De Ren Yang | M | 60 |
Zhejiang University
| 36 years |
| Li Jia Fu | M | 61 | 3 years | |
| Feiyang Ding | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Zheng Yao | M | 67 |
Zhejiang University
| 36 years |
| Yong Gong Zhai | M | 63 | 3 years | |
| Yu Ping Sun | F | 51 | 3 years | |
| Andrew Reynolds | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 5 years |
| Qiang Sun | M | 43 | 2 years | |
| Hua Dong Tang | M | 51 | 2 years | |
| Peng Hui Chen | M | 52 | 5 years | |
| Peter Joe Pitts | M | 65 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Chong Sun Chung | M | 48 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 years |
| Nan Peng Shen | M | 57 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 19 years |
| Tian Long Hu | M | 47 | 4 years | |
| Shing Cheung Wong | M | 37 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | - |
| Hao Zhang | M | 42 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Timothy Nieters | M | 52 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 9 years |
| Xiao Cong Xiong | M | 42 | 6 years | |
| Qian Sun | M | 51 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 18 years |
| Rui Luo | M | - |
Qingdao Raisecare Biotechnology Co., Ltd.
Qingdao Raisecare Biotechnology Co., Ltd. Medical SpecialtiesHealth Technology Qingdao Raisecare Biotechnology Co., Ltd. is a pharmaceutical company founded in 2016. The private company is based in Qingdao, China and develops and promotes pharmaceutical chemicals and products. | - |
| Xi Bin Wen | M | - |
Qingdao Raisecare Biotechnology Co., Ltd.
Qingdao Raisecare Biotechnology Co., Ltd. Medical SpecialtiesHealth Technology Qingdao Raisecare Biotechnology Co., Ltd. is a pharmaceutical company founded in 2016. The private company is based in Qingdao, China and develops and promotes pharmaceutical chemicals and products. | 4 years |
| Li Yong Wang | M | - |
Qingdao Raisecare Biotechnology Co., Ltd.
Qingdao Raisecare Biotechnology Co., Ltd. Medical SpecialtiesHealth Technology Qingdao Raisecare Biotechnology Co., Ltd. is a pharmaceutical company founded in 2016. The private company is based in Qingdao, China and develops and promotes pharmaceutical chemicals and products. | 4 years |
| Shu Jian Zhang | M | - |
Qingdao Raisecare Biotechnology Co., Ltd.
Qingdao Raisecare Biotechnology Co., Ltd. Medical SpecialtiesHealth Technology Qingdao Raisecare Biotechnology Co., Ltd. is a pharmaceutical company founded in 2016. The private company is based in Qingdao, China and develops and promotes pharmaceutical chemicals and products. | 4 years |
| Shi Na Zhang | F | 40 | 3 years | |
| Ruodi Hu | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Tiantian He | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Colin Guo | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 11 years |
| Yuan Gong | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Casey Wang | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Quan Fang Hu | F | 61 | 2 years | |
| Wenji Jin | M | 52 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Jia Zhai | M | 41 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Wayne Guo | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Qing Sheng Zheng | M | 47 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Xing Liu | M | 53 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 17 years |
| Chong En Bai | M | 61 |
Tsinghua University
| 6 years |
| Xu Liu | M | 60 |
Zhejiang University
| 32 years |
| Bo Geng Li | M | 66 |
Zhejiang University
| 30 years |
| Cen Wang | M | 51 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Angelica Cheung | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 3 years |
| Zhang Xiang Fan | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Caroline Fu | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Enita Pu | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Lynn Yang | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Jia Jia Zou | F | 46 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Yi Lin | M | 55 | 5 years | |
| Ling Yang | F | 44 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Michael William Pennington | M | 62 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 years |
| Rock Wang | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Liu Jiang | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Allen Hu | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Cui Ping Gu | M | 44 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Kui Zhou | M | 56 |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Cyber Cao | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 6 years |
| Shirley Feng | F | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | 6 years |
| Robert Zhang | M | - |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | - |
| Jian Liu | M | 52 |
Tsinghua University
| 7 years |
| Di Nan | F | 36 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zhi Song Tang | M | 51 | 6 years | |
| Ming Zhong Fu | F | 74 | - | |
| Bao Qun Fan | M | 52 |
Zhejiang University
| 4 years |
| Qiang Jun Xue | M | 55 |
Zhejiang University
| 6 years |
| Shui Hong | M | - |
Tsinghua University
| 6 years |
| Wen Chao Shen | M | - |
Tsinghua University
| 7 years |
| Zheng Bian | M | - |
Tsinghua University
| 6 years |
| Huimin Wang | M | 67 |
Zhejiang University
| 3 years |
| Zheng Xiang | M | 36 |
Tsinghua University
| 6 years |
| Chao Dou | M | 33 |
Tsinghua University
| 8 years |
| Xiaolu Sun | M | 48 |
Zhejiang University
| 7 years |
| Ling Yao | F | - |
Tsinghua University
| 6 years |
| Yong Fei Ye | M | 52 |
Zhejiang University
| 6 years |
| Jian Ji | M | 54 |
Zhejiang University
| 8 years |
| Xing Gao Liu | M | 55 |
Zhejiang University
| 5 years |
| Lie Zhang | M | 49 |
Zhejiang University
Tsinghua University
| 8 years |
| Tao He | M | 38 |
Tsinghua University
| 6 years |
| Nan Wen Zhu | M | 56 |
Zhejiang University
| 6 years |
| Cheng Huang | M | 52 |
Zhejiang University
| 8 years |
| Zhong Liang Chen | M | 52 |
Zhejiang University
| 6 years |
| Bin Guo | M | 52 |
Zhejiang University
| 8 years |
| Peng Cheng Ji | M | 43 |
Tsinghua University
| 10 years |
| Jiang Liu | M | - |
Tsinghua University
| 6 years |
| Li Zhang | F | 39 |
Tsinghua University
| 6 years |
| Peng Hock Cheah | M | 71 | - | |
| Yu Ming Ye | M | 36 |
Tsinghua University
| 6 years |
| Sheng Wang | M | - |
Tsinghua University
| 6 years |
| Jian Hua Fang | M | 61 |
Zhejiang University
| 5 years |
| Zhong Yi Su | M | 67 | 6 years | |
| Xiao Bo Wu | M | 64 |
Zhejiang University
| 4 years |
| Shihao Qi | M | 29 |
Tsinghua University
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 59 | 59.00% |
| Hong Kong | 31 | 31.00% |
| United States | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Xiao Bo Lu
- Personal Network
